Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avutometinib + Defactinib in Metastatic Diffuse Gastric Cancer
NCT06487221Phase 2Recruiting
- Start
- Oct 2024
- Primary completion
- Nov 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of avutometinib, defactinib in gastric cancer (GC). Started Oct 2024; status: recruiting.
02
Drugs
avutometinibdefactinib
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT06487221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06487221.